Vitamin B6: A molecule for human health?

Molecules

Volumn 15, Issue 1, 2010, Pages 442-459

  Hellmann, Hanjo ^a   Mooney, Sutton ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

De novo; Health; PDX; Salvage; Vitamin B6

Indexed keywords

AMINO ACID; PYRIDOXINE;

BIOSYNTHESIS; CHEMISTRY; HEALTH; HUMAN; METABOLISM; REVIEW;

AMINO ACIDS; HEALTH; HUMANS; VITAMIN B 6;

EID: 75749143884     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15010442     Document Type: Review

References (104)

1. Roje, S. Vitamin B biosynthesis in plants. Phytochemistry 2007, 68, 1904-1921.
2. Birch, T.W.; Gyorgy, P.; Harris, L.J. The vitamin B(2) complex. Differentiation of the antiblacktongue and the "P.-P." factors from lactoflavin and vitamin B(6) (so-called "rat pellagra" factor). Parts I-VI. Biochem. J. 1935, 29, 2830-2850.
3. Percudani, R.; Peracchi, A. The B6 database: a tool for the description and classification of vitamin B6-dependent enzymatic activities and of the corresponding protein families. BMC Bioinformatics 2009, 10, 273.
4. Brouwer, D.A.; Welten, H.T.; van Doormaal, J.J.; Reijngoud, D.J.; Muskiet, F.A. Recommended dietary allowance of folic acid is insufficient for optimal homocysteine levels. Ned. Tijdschr. Geneeskd. 1998,142, 782-786.
5. 5. Amadasi, A.; Bertoldi, M.; Contestabile, R.; Bettati, S.; Cellini, B.; di Salvo, MX.; BorriVoltattorni, C.; Bossa, F.; Mozzarelli, A. Pyridoxal 5'-phosphate enzymes as targets for therapeutic agents. Curr. Med. Chem. 2007,14, 1291-1324. (Pubitemid 46746362)
6. Di Giovine, P. PLPMDB: pyridoxal-5'-phosphate dependent enzymes mutants database. Bioinformatics 2004, 20, 3652-3653.
7. Denesyuk, A.I.; Denessiouk, K.A.; Korpela, T.; Johnson, M.S. Functional attributes of the phosphate group binding cup of pyridoxal phosphate-dependent enzymes. J. Mol. Biol. 2002, 316, 155-172.
8. Mooney, S.; Leuendorf, J.E.; Hendrickson, C.; Hellmann, H. Vitamin B6: a long known compound of surprising complexity. Molecules 2009,14, 329-351.
9. 9. Fitzpatrick, T.B.; Amrhein, N.; Kappes, B.; Macheroux, P.; Tews, I.; Raschle, T. Two independent routes of de novo vitamin B6 biosynthesis: not that different after all. Biochem. J. 2007, 407,1-13. (Pubitemid 47535575)
10. 10. Drewke, C.; Leistner, E. Biosynthesis of vitamin B6 and structurally related derivatives. Vitam. Horm. 2001, 61, 121-155. (Pubitemid 33805693)
11. 11. Drewke, C.; Klein, M.; Clade, D.; Arenz, A.; Muller, R.; Leistner, E. 4-O-phosphoryl-Lthreonine, a substrate of the pdxC(serC) gene product involved in vitamin B6 biosynthesis. FEBS Lett. 1996, 390, 179-182. (Pubitemid 26281196)
12. Notheis, C.; Drewke, C.; Leistner, E. Purification and characterization of the pyridoxol-5'phosphate:oxygen oxidoreductase (deaminating) from Escherichia coli. Biochim. Biophys. Acta 1995, 1247, 265-1211
13. 13. Mittenhuber, G. Phylogenetic analyses and comparative genomics of vitamin B6 (pyridoxine) and pyridoxal phosphate biosynthesis pathways. J. Mol. Microbiol. Biotechnol. 2001, 3, 1-20. (Pubitemid 32094166)
14. Tambasco-Studart, M.; Titiz, O.; Raschle, T.; Forster, G.; Amrhein, N.; Fitzpatrick, T.B. Vitamin B6 biosynthesis in higher plants. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 13687-13692.
15. 15. Burns, K.E.; Xiang, Y.; Kinsland, C.L.; McLafferty, F.W.; Begley, T.P. Reconstitution and biochemical characterization of a new pyridoxal-5'-phosphate biosynthetic pathway. J. Am. Chem. Soc. 2005,127, 3682-3683. (Pubitemid 40411393)
16. Tanaka, T.; Tateno, Y.; Gojobori, T. Evolution of vitamin B6 (pyridoxine) metabolism by gain and loss of genes. Mol. Biol. Evol. 2005, 22, 243-2450.
17. 17. Wagner, S.; Bernhardt, A.; Leuendorf, J. E.; Drewke, C.; Lytovchenko, A.; Mujahed, N.; Gurgui, C.; Frommer, W.B.; Leistner, E.; Fernie, A.R.; Hellmann, H. Analysis of the Arabidopsis rsr4l/pdx1-3 mutant reveals the critical function of the PDX1 protein family in metabolism, development, and vitamin B6 biosynthesis. Plant Cell 2006,18, 1722-1735. (Pubitemid 44025555)
18. Neuwirth, M.; Strohmeier, M.; Windeisen, V.; Wallner, S.; Deller, S.; Rippe, K.; Sinning, I.; Macheroux, P.; Tews, I. X-ray crystal structure of Saccharomyces cerevisiae Pdx1 provides insights into the oligomeric nature of PLP synthases. FEBS Lett. 2009, 583, 2179-2186.
19. Raschle, T.; Speziga, D.; Kress, W.; Moccand, C.; Gehrig, P.; Amrhein, N.; Weber-Ban, E.; Fitzpatrick, T.B. Intersubunit crosstalk in pyridoxal 5'-phosphate synthase, co-ordinated by the C-terminus of the synthase subunit. J. Biol. Chem. 2008, 284, 7706-7718.
20. Gdynia, H.J.; Muller, T.; Sperfeld, A.D.; Kuhnlein, P.; Otto, M.; Kassubek, J.; Ludolph, A. C. Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6. Neuromuscul. Disord. 2008, 18, 156-158.
21. 21. Neuwirth, M.; Flicker, K.; Strohmeier, M.; Tews, I.; Macheroux, P. Thermodynamic characterization of the protein-protein interaction in the heteromeric Bacillus subtilis pyridoxalphosphate synthase. Biochemistry 2007, 46, 5131-5139. (Pubitemid 46683011)
22. Strohmeier, M.; Raschle, T.; Mazurkiewicz, J.; Rippe, K.; Sinning, I.; Fitzpatrick, T. B.; Tews, I. Structure of a bacterial pyridoxal 5'-phosphate synthase complex. Proc. Natl. Acad. Sci. USA2006, 103, 19284-19289.
23. 23. Gengenbacher, M.; Fitzpatrick, T.B.; Raschle, T.; Flicker, K.; Sinning, I.; Muller, S.; Macheroux, P.; Tews, I.; Kappes, B. Vitamin B6 biosynthesis by the malaria parasite Plasmodium falciparum: biochemical and structural insights. J. Biol. Chem. 2006, 281, 3633-3641. (Pubitemid 43845981)
24. Zein, F.; Zhang, Y.; Kang, Y.N.; Burns, K.; Begley, T.P.; Ealick, S.E. Structural insights into the mechanism of the PLP synthase holoenzyme from Thermotoga maritima. Biochemistry 2006, 45, 14609-14620.
25. Gonzalez, E.; Danehower, D.; Daub, M.E. Vitamer levels, stress response, enzyme activity, and gene regulation of Arabidopsis lines mutant in the pyridoxine/pyridoxamine 5'-phosphate oxidase (PDX3) and the pyridoxal kinase (SOS4) genes involved in the vitamin B6 salvage pathway. Plant Physiol. 2007,145, 985-996.
26. Ohdake, S. Isolation of "Oryzanin" (Antineuritic Vitamin) from Rice-polishings Bull Agri. Chem. Soc.Jpn. 1932, 8, 11-46.
27. Oka, T. Vitamin B6. Nippon Rinsho 1999, 57, 2199-2204.
28. Nogueira, A.; Duarte, A.F.; Magina, S.; Azevedo, F. Pellagra associated with esophageal carcinoma and alcoholism. Dermatol. Online J. 2009,15, 8.
29. Hendricks, W.M. Pellagra and pellagralike dermatoses: etiology, differential diagnosis, dermatopathology, and treatment. Semin. Dermatol. 1991, 10, 282-292.
30. Morris, M.S.; Picciano, M.F.; Jacques, P.F.; Selhub, J. Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004. Am. J. Clin. Nutr. 2008, 87, 1446-1454.
31. Perry, T.; Holloway, H.W.; Weerasuriya, A.; Mouton, P.R.; Duffy, K.; Mattison, J.A.; Greig, N.H. Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Exp. Neurol. 2007, 203, 293-301.
32. Albin, R.L.; Albers, J.W.; Greenberg, H.S.; Townsend, J.B.; Lynn, R.B.; Burke, J.M. Jr.; Alessi, A.G. Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology 1987, 37, 1729-1732.
33. 33. Lu, T.; Xu, Y.; Monttinen, E.S.; Kato, N. Supplementing vitamin B6 to a low vitamin B6 diet exaggerates UVB-induced skin tumorigenesis in DMBA-treated hairless mice. J. Nutr. Sci. Vitaminol. (Tokyo) 2008, 54, 262-265. (Pubitemid 352008312)
34. Wondrak, G.T.; Roberts, M.J.; Jacobson, M.K.; Jacobson, EX. 3-hydroxypyridine chromophores are endogenous sensitizers of photooxidative stress in human skin cells. J. Biol. Chem. 2004, 279, 30009-30020.
35. 35. Maeda, T.; Taguchi, H.; Minami, H.; Sato, K.; Shiga, T.; Kosaka, H.; Yoshikawa, K. Vitamin B6 phototoxicity induced by UVA radiation. Arch. Dermatol. Res. 2000, 292, 562-567. (Pubitemid 32003040)
36. Muhia, D.K.; Swales, C. A.; Deng, W.; Kelly, J.M.; Baker, D.A. The gametocyte-activating factor xanthurenic acid stimulates an increase in membrane-associated guanylyl cyclase activity in the human malaria parasite Plasmodium falciparum. Mol. Microbiol. 2001, 42, 553-560.
37. Rossi, F.; Garavaglia, S.; Giovenzana, G.B.; Area, B.; Li, J.; Rizzi, M. Crystal structure of the Anopheles gambiae 3-hydroxykynurenine transaminase. Proc. Natl. Acad. Sci. USA 2006, 103, 5711-6576
38. 38. Rossi, F.; Lombardo, F.; Paglino, A.; Cassani, C.; Miglio, G.; Arca, B.; Rizzi, M. Identification and biochemical characterization of the Anopheles gambiae 3-hydroxykynurenine transaminase. Febs J. 2005, 272, 5653-5662. (Pubitemid 41579423)
39. Marti-Carvajal, AJ.; Sola, I.; Lathyris, D.; Salanti, G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst. Rev. 2009, CD006612.
40. Muller, I.B.; Wu, F.; Bergmann, B.; Knockel, J.; Walter, R.D.; Gehring, H.; Wrenger, C. Poisoning pyridoxal 5-phosphate-dependent enzymes: a new strategy to target the malaria parasite Plasmodium falciparum. PLoS One 2009,4, 4406.
41. 41. Wrenger, C.; Eschbach, MX.; Muller, I.B.; Warnecke, D.; Walter, R.D. Analysis of the vitamin B6 biosynthesis pathway in the human malaria parasite Plasmodium falciparum. J. Biol. Chem. 2005, 280, 5242-5248. (Pubitemid 40279996)
42. Pegg, A.E.; McGovern, K.A.; Wiest, L. Decarboxylation of alpha-difluoromethylornithine by ornithine decarboxylase. Biochem. J. 1987, 241, 305-307.
43. Poulin, R.; Lu, L.; Ackermann, B.; Bey, P.; Pegg, A. E. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. J. Biol. Chem. 1992, 267, 15015-15018.
44. Kern, A.D.; Oliveira, M.A.; Coffino, P.; Hackert, M.L. Structure of mammalian ornithine decarboxylase at 1.6 A resolution: stereochemical implications of PLP-dependent amino acid decarboxylases. Structure 1999, 7, 567-581.
45. Kernebeck, T.; Lohse, A.W.; Grotzinger, J.A bioinformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas. Hepatology 2001, 34, 230-233.
46. Krauth-Siegel, L.R.; Comini, M.A.; Schlecker, T. The trypanothione system. Subcell. Biochem. 2007,44,231-251.
47. Fairlamb, A.H.; Blackburn, P.; Ulrich, P.; Chait, B.T.; Cerami, A. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 1985, 227, 1485-1487.
48. 48. Snell, K.; Natsumeda, Y.; EbIe, J.N.; Glover, JL.; Weber, G. Enzymic imbalance in serine metabolism in human colon carcinoma and rat sarcoma. Br. J. Cancer 1988, 57, 87-90. (Pubitemid 18067110)
49. Snell, K.; Natsumeda, Y.; Weber, G. The modulation of serine metabolism in hepatoma 3924A during different phases of cellular proliferation in culture. Biochem. J. 1987, 245, 609-612.
50. Chang, S.J. Vitamin B6 antagonists alter the function and ultrastructure of mice endothelial cells. J. Nutr. Sci. Vitaminol. (Tokyo) 2000,46, 149-153.
51. 51. Renwick, S.B.; Skelly, J.V.; Chave, K.J.; Sanders, P.G.; Snell, K.; Baumann, U Purification, crystallization and preliminary X-ray analysis of human recombinant cytosolic serine hydroxymethyltransferase. Acta Crystallogr. D. Biol. Crystallogr. 1998,54, 1030-1031. (Pubitemid 28443625)
52. Pires, A.R.; Araujo, A.N.; Montenegro, M.C; Chocholous, P.; Solich, P. New ionophores for vitamin Bl and vitamin B6 Potentiometrie sensors for multivitaminic control. J. Pharm. Biomed. Anal. 2008,45,683-691.
53. 53. Ishihara, J.; Iso, H.; Inoue, M.; Iwasaki, M.; Okada, K.; Kita, Y.; Kokubo, Y.; Okayama, A.; Tsugane, S. Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Center-Based Prospective Study Cohort I. J. Am. Coll. Nutr. 2008, 27, 127-136. (Pubitemid 351600532)
54. 54. Czeizel, A.E.; Puho, E.; Banhidy, F.; Acs, N. Oral pyridoxine during pregnancy : potential protective effect for cardiovascular malformations. Drugs R. D. 2004, 5, 259-269. (Pubitemid 39429514)
55. Merrill, R.M.; Taylor, P.; Aldana, S.G. Coronary Health Improvement Project (CHIP) is associated with improved nutrient intake and decreased depression. Nutrition 2008, 24, 314-321.
56. Booth, GX.; Wang, E.E. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. CMAJ 2000,163, 21-29.
57. 57. Nozaki, T.; Shigeta, Y.; Saito-Nakano, Y.; Imada, M.; Kruger, W.D. Characterization of transsulfuration and cysteine biosynthetic pathways in the protozoan hemoflagellate, Trypanosoma cruzi. Isolation and molecular characterization of cystathionine beta-synthase and serine acetyltransferase from Trypanosoma. J. Biol. Chem. 2001, 276, 6516-6523. (Pubitemid 37373514)
58. 58. Graham, I.M.; Daly, L.E.; Refsum, H.M.; Robinson, K.; Brattstrom, L.E.; Ueland, P.M.; PalmaReis, RJ.; Boers, G.H.; Sheahan, R.G.; Israelsson, B.; Uiterwaal, C. S.; Meleady, R.; McMaster, D.; Verhoef, P.; Witteman, J.; Rubba, P.; Bellet, H.; Wautrecht, J.C.; de Valk, H.W.; Sales Luis, A.C.; Parrot-Rouland, F.M.; Tan, K.S.; Higgins, I.; Garcon, D.; Andria, G. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997, 277, 1775-1781. (Pubitemid 27247163)
59. Lal, K.J.; Dakshinamurti, K. The relationship between low-calcium-induced increase in systolic blood pressure and vitamin B6. J. Hypertens. 1995,13, 327-332.
60. 60. Lal, K.J.; Dakshinamurti, K.; Thliveris, J. The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. J. Hypertens. 1996,14, 355-363. (Pubitemid 26137633)
61. Dakshinamurti, K.; Lal, K.J.; Ganguly, P.K. Hypertension, calcium channel and pyridoxine (vitamin B6). Mol. Cell Biochem. 1998, 188, 137-148.
62. Aybak, M.; Sermet, A.; Ayyildiz, M.O.; Karakilcik, A.Z. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittelforschung 1995,45, 1271-1273.
63. Dakshinamurti, K.; Dakshinamurti, S. Blood pressure regulation and micronutrients. Nutr. Res. Rev. 2001,14, 3-44.
64. 64. Okuda, T.; Sumiya, T.; Iwai, N.; Miyata, T. Pyridoxine 5'-phosphate oxidase is a candidate gene responsible for hypertension in Dahl-S rats. Biochem. Biophys. Res. Commun. 2004, 313, 647-653 (Pubitemid 38021880)
65. Lieber, C.S. Mechanism of ethanol induced hepatic injury. Pharmacol. Ther. 1990,46, 1-41.
66. Vasdev, S.; Whalen, M.; Ford, C. A.; Longerich, L.; Prabhakaran, V.; Parai, S. Ethanol- and threonine-induced hypertension in rats: a common mechanism. Can. J. Cardiol. 1995, 11, 807-815.
67. 67. Vasdev, S.; Wadhawan, S.; Ford, C. A.; Parai, S.; Longerich, L.; Gadag, V. Dietary vitamin B6 supplementation prevents ethanol-induced hypertension in rats. Nutr. Metab. Cardiovasc. Dis. 1999, 9, 55-63. (Pubitemid 129634400)
68. Gloria, L.; Cravo, M.; Camilo, M.E.; Resende, M.; Cardoso, J.N.; Oliveira, A.G.; Leitao, C.N.; Mira, F.C. Nutritional deficiencies in chronic alcoholics: relation to dietary intake and alcohol consumption. Am. J. Gastroenterol. 1997, 92, 485-489.
69. Huber, K.H.; Rexroth, W.; Werle, E.; Koeth, T.; Weicker, H.; Hild, R. Sympathetic neuronal activity in diabetic and non-diabetic subjects with peripheral arterial occlusive disease. Klin. Wochenschr. 1991, 69, 233-238.
70. Cicila, G.T. Strategy for uncovering complex determinants of hypertension using animal models. Curr. Hypertens. Rep. 2000, 2, 217-226.
71. MacKenzie, K.E.; Wiltshire, EJ.; Gent, R.; Hirte, C.; Piotto, L.; Couper, J. J. Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics 2006, 118, 242-253.
72. 72. Nakamura, S.; Li, H.; Adijiang, A.; Pischetsrieder, M.; Niwa, T. Pyridoxal phosphate prevents progression of diabetic nephropathy. Nephrol. Dial. Transplant 2007, 22, 2165-2174. (Pubitemid 47244693)
73. 73. Adrover, M.; Vilanova, B.; Munoz, F.; Donoso, J. Inhibition of glycosylation processes: the reaction between pyridoxamine and glucose. Chem. Biodivers. 2005, 2, 964-975. (Pubitemid 41057416)
74. Nagore, E.; Insa, A.; Sanmartin, O. Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management. Am. J. Clin. Dermatol. 2000, 1, 225-234.
75. Taylor, BV.; Oudit, G.Y.; Evans, M. Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature. Can. Fam. Physician 2000,46, 2236-2245.
76. Matsubara, K.; Matsumoto, H.; Mizushina, Y.; Lee, J.S.; Kato, N. Inhibitory effect of pyridoxal 5'-phosphate on endothelial cell proliferation, replicative DNA polymerase and DNA topoisomerase. Int. J. Mol. Med. 2003,12, 51-55.
77. Bostom, A.G.; Carpenter, M.A.; Kusek, J.W.; Hunsicker, L.G.; Pfeffer, M.A.; Levey, A.S.; Jacques, P.F.; McKenney, J. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial. Am. Heart J. 2006,152, 448.
78. Menon, V.; Wang, X.; Greene, T.; Beck, G. J.; Kusek, J.W.; Selhub, J.; Levey, A.S.; Sarnak, M.J. Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins. Kidney Int. 2005, 67, 1539-1546.
79. Adrover, M.; Vilanova, B.; Frau, J.; Munoz, F.; Donoso, J. A comparative study of the chemical reactivity of pyridoxamine, Ac-Phe-Lys and Ac-Cys with various glycating carbonyl compounds. Amino Acids 2009, 36, 437-448.
80. Metz, T.O.; Alderson, N.L.; Thorpe, S.R.; Baynes, J.W. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Arch. Biochem. Biophys. 2003,419, 41-49.
81. Voziyan, P.A.; Metz, T.O.; Baynes, J.W.; Hudson, B.G. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J. Biol. Chem. 2002, 277, 3397-3403.
82. Berger, M.; Gray, J.A.; Roth, B.L. The expanded biology of serotonin. Annu. Rev. Med. 2009, 60, 355-366
83. Matxain, J.M.; Padro, D.; Ristila, M.; Strid, A.; Eriksson, L.A. Evidence of high *OH radical quenching efficiency by vitamin B6. J. Phys. Chem. B. 2009,113, 9629-9632.
84. Belelli, D.; Harrison, NX.; Maguire, J.; Macdonald, R.L.; Walker, M.C.; Cope, D.W. Extrasynaptic GABAA receptors: form, pharmacology, and function. J. Neurosci. 2009, 29, 12757-12763.
85. 85. Hvas, A.M.; Juul, S.; Bech, P.; Nexo, E. Vitamin B6 level is associated with symptoms of depression. Psychother. Psychosom. 2004, 73, 340-343. (Pubitemid 39370522)
86. 86. Hoffmann, G.F.; Schmitt, B.; Windfuhr, M.; Wagner, N.; Strehl, H.; Bagci, S.; Franz, A. R.; Mills, P.B.; Clayton, P.T.; Baumgartner, M.R.; Steinmann, B.; Bast, T.; Wolf, N.I.; Zschocke, J. Pyridoxal 5'-phosphate may be curative in early-onset epileptic encephalopathy. J. Inherit. Metab. Dis. 2007, 30, 96-99. (Pubitemid 46140231)
87. Lott, I.T.; Coulombe, T.; Di Paolo, RV.; Richardson, E.P. Jr.; Levy, H.L. Vitamin B6-dependent seizures: pathology and chemical findings in brain. Neurology 1978, 28, 47-54.
88. McCarty, M.F. High-dose pyridoxine as an 'anti-stress' strategy. Med. Hypotheses 2000, 54, 803-807.
89. 89. Leuendorf, J.E.; Genau, A.; Szewczyk, A.; Mooney, S.; Drewke, C.; Leistner, E.; Hellmann, H. The Pdxl family is structurally and functionally conserved between Arabidopsis thaliana and Ginkgo biloba. FEBS J. 2008, 275, 960-969. (Pubitemid 351230218)
90. 90. Kästner, U.; Hallmen, C.; Wiese, M.; Leistner, E.; Drewke, C. The human pyridoxal kinase, a plausible target for ginkgotoxin from Ginkgo biloba. FEBS J. 2007, 274, 1036-1045. (Pubitemid 46204422)
91. Denslow, S.A.; Walls, A.A.; Daub, M.E. Regulation of biosynthetic genes and antioxidant properties of vitamin B6 vitamers during plant defense responses. Physiol. Mol. Plant Path. 2005, 66, 244-255.
92. Bilski, P.; Li, M.Y.; Ehrenshaft, M.; Daub, M.E.; Chignell, C. F. Vitamin B6 (pyridoxine) and its derivatives are efficient singlet oxygen quenchers and potential fungal antioxidants. Photochem. Photobiol. 2000, 71, 129-134.
93. Ehrenshaft, M.; Jenns, A.E.; Chung, K.R.; Daub, M.E. SOR1, a gene required for photosensitizer and singlet oxygen resistance in Cercospora fungi, is highly conserved in divergent organisms. Mol Cell 1998, 1, 603-609.
94. 94. Chen, H.; Xiong, L. Pyridoxine is required for post-embryonic root development and tolerance to osmotic and oxidative stresses. Plant J. 2005,44, 396-408. (Pubitemid 43919869)
95. 95. Chumnantana, R.; Yokochi, N.; Yagi, T. Vitamin B6 compounds prevent the death of yeast cells due to menadione, a reactive oxygen generator. Biochim. Biophys. Acta 2005, 1722, 84-91. (Pubitemid 40222409)
96. 96. DiSorbo, D.M.; Wagner, R. Jr.; Nathanson, L. In vivo and in vitro inhibition of B16 melanoma growth by vitamin B6. Nutr. Cancer 1985, 7, 43-52. (Pubitemid 16238107)
97. DiSorbo, D.M.; Nathanson, L. High-dose pyridoxal supplemented culture medium inhibits the growth of a human malignant melanoma cell line. Nutr. Cancer 1983, 5, 10-15.
98. 98. Komatsu, S.; Yanaka, N.; Matsubara, K.; Kato, N. Antitumor effect of vitamin B6 and its mechanisms. Biochim. Biophys. Acta 2003,1647, 127-130. (Pubitemid 38234644)
99. 99. Stolzenberg-Solomon, R.Z.; Albanês, D.; Nieto, F.J.; Hartman, T.J.; Tangrea, J.A.; Rautalahti, M.; Sehlub, J.; Virtamo, J.; Taylor, P.R. Pancreatic cancer risk and nutrition-related methylgroup availability indicators in male smokers. J. Natl. Cancer Inst. 1999, 91, 535-541. (Pubitemid 29157062)
100. Harbige, L.S. Nutrition and immunity with emphasis on infection and autoimmune disease. Nutr. Health 1996,10, 285-312.
101. Delport, R.; Ubbink, J.B.; Bosman, H.; Bissbort, S.; Vermaak, W.J. Altered vitamin B6 homeostasis during aminophylline infusion in the beagle dog. Int. J. Vitam. Nutr. Res. 1990, 60, 35-40.
102. 102. Delport, R.; Ubbink, J.B.; Serfontein, W.J.; Becker, P.J.; Walters, L. Vitamin B6 nutritional status in asthma: the effect of theophylline therapy on plasma pyridoxal-5'-phosphate and pyridoxal levels. Int. J. Vitam. Nutr. Res. 1988, 58, 67-72. (Pubitemid 18108725)
103. 103. van den Berg, H.; Louwerse, E.S.; Bruinse, H.W.; Thissen, J.T.; Schrijver, J. Vitamin B6 status of women suffering from premenstrual syndrome. Hum. Nutr. Clin. Nutr. 1986,40, 441-450. (Pubitemid 17189143)
104. Bernstein, A.X. Vitamin B6 in clinical neurology. Ann. N. Y. Acad. Sci. 1990, 585, 250-260.